Helmerich & Payne, INC

Market Movers (8-K)

NYSE
Helmerich & Payne, Inc. announced a quarterly cash dividend of $0.25 per share on its common stock.
NYSE
Helmerich & Payne announced the retirement of CFO J. Kevin Vann and the appointment of Todd Scruggs as his successor, effective July 1, 2026.
NYSE
Helmerich & Payne, Inc. stockholders approved the Amended & Restated 2024 Omnibus Incentive Plan and elected ten directors at the 2026 Annual Meeting.
NYSE
Helmerich & Payne, Inc. announced a quarterly cash dividend of $0.25 per share, payable on June 1, 2026.
NYSE
Helmerich & Payne reported a consolidated net loss of $(97) million for its first fiscal quarter ended December 31, 2025, primarily due to a $103 million non-cash impairment charge.
Worse than expected
NYSE
Helmerich & Payne, Inc. announced the retirement of CEO John Lindsay and the appointment of President Raymond John Trey Adams III as his successor, effective March 4, 2026.

Quarterly Earnings (10-Q)

NYSE
Helmerich & Payne reports a net loss for the quarter ended March 31, 2026, impacted by asset impairments and integration costs, despite a growing contract backlog.
Worse than expected
NYSE
Helmerich & Payne, Inc. reported a significant net loss for the third fiscal quarter of 2025, driven by goodwill impairment charges and increased expenses following the KCA Deutag acquisition, despite higher revenues.
Worse than expected
Delay expected
Capital raise
NYSE
Helmerich & Payne reports Q2 FY25 results reflecting the impact of the KCA Deutag acquisition, increased international activity, and market uncertainties.
Worse than expected
NYSE
Helmerich & Payne's Q1 FY25 net income decreased to $54.8 million, while the company completed the acquisition of KCA Deutag.
Worse than expected
NYSE
Helmerich & Payne's Q3 2024 earnings decreased slightly year-over-year, while the company announced a major acquisition of KCA Deutag.
Worse than expected
Capital raise
NYSE
Helmerich & Payne's Q2 2024 earnings saw a decrease in revenue primarily due to lower activity in North America and the Gulf of Mexico, despite some gains in international markets.
Worse than expected

Annual Reports (10-K)

NYSE
Helmerich & Payne reported a net loss of $163.7 million for fiscal year 2025, primarily due to a significant goodwill impairment and acquisition-related costs following the KCA Deutag acquisition.
Worse than expected
NYSE
Helmerich & Payne's fiscal year 2024 saw a decrease in revenue, alongside the announcement of a significant acquisition of KCA Deutag.
Capital raise
Worse than expected

Insider Trading (Form 4)

NYSE
Todd N. Scruggs, SVP, CFO of Helmerich & Payne, Inc., reported a transaction in 2,150 shares of common stock on July 31, 2026.
NYSE
Michael Lennox, EVP, WESTERN HEMISPHERE LAND of Helmerich & Payne, Inc., sold 5,000 shares of common stock on July 22, 2026 for $35.00 per share.
NYSE
VP and CAO Sara Momper disposed of 440 shares of Helmerich & Payne common stock to cover tax obligations.
NYSE
Cara M. Hair, SVP of Corporate Services & CLO at Helmerich & Payne, Inc., reported a sale of 28,345 shares of common stock.
NYSE
Helmerich & Payne's SVP of Corporate Services and CLO, Cara M. Hair, sold 58,771 shares of common stock for approximately $36.62 per share.
NYSE
Helmerich & Payne Director John Zeglis reported the acquisition of 5,273 shares of common stock under a Rule 10b5-1 plan.

Proxy Statements (Def-14A)

NYSE
Helmerich & Payne, Inc. announced its 2026 Annual Meeting of Stockholders to be held virtually on March 4, 2026, to vote on director elections, auditor ratification, executive compensation, and an incentive plan.
NYSE
Helmerich & Payne, Inc. reports significant fiscal 2025 achievements including a major acquisition, accelerated debt repayment, and strong operational performance in North America, while preparing for a CEO transition.
Worse than expected
NYSE
Helmerich & Payne's 2025 Annual Meeting will be held virtually on March 5, 2025, with shareholders voting on the election of directors, ratification of auditors, and executive compensation.
NYSE
Helmerich & Payne (H&P) reports a strong fiscal year 2024, marked by international expansion, strategic acquisitions, and continued returns to stockholders, despite industry-wide challenges.

Schedule 13G - Passive Investments

NYSE
Vanguard Portfolio Management has reported beneficial ownership of 6.15% of Helmerich & Payne Inc.'s common stock as of March 31, 2026.
NYSE
The Vanguard Group filed an amended Schedule 13G for Helmerich & Payne Inc., reporting 0% beneficial ownership following an internal realignment.
NYSE
Dimensional Fund Advisors LP has disclosed a 5.2% beneficial ownership stake in Helmerich & Payne Inc. common stock as of December 31, 2025.
NYSE
Helmerich & Payne, Inc. and its subsidiary have disclosed a 4.97% beneficial ownership stake in Tamboran Resources Corporation, totaling 1,018,850 shares.
NYSE
Dimensional Fund Advisors LP has disclosed a 5.0% beneficial ownership stake in Helmerich & Payne Inc. common stock as of September 30, 2025.
NYSE
BlackRock, Inc. has filed an updated Schedule 13G, revealing a 14.4% beneficial ownership stake in Helmerich & Payne, Inc. as of June 30, 2025.